Synthetic and endogenousPPARγ ligands decrease the high COX-2 expression associated withseveral malignancies including cervical [48] and liver cancers[49] and forced PPAR over-expression decreases COX-2 levels inlung cancer cells [38]. This evidence concerns the gene PTGS2 and liver cancer.